Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)
Clinical trial NCT01910662 · COMPLETED
Trial details
- NCT number
- NCT01910662
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-22
- Primary completion
- 2013-11-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.